Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot Password? Reset your password

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login (Shibboleth)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Table of Contents
Vol. 15, No. 5, 2006
Issue release date: August 2006
Section title: Case Report
Open Access Gateway
Med Princ Pract 2006;15:396–400

Carotid Body Tumors and Adrenal Pheochromocytomas in Siblings of a Turkish Family

Erem C.a · Hacihasanoglu A.a · Cinel A.b · Isik A.C.U.c · Reis A.d · Sari A.e · Ersöz H.Ö.a · Ukinç K.a
aDivision of Endocrinology and Metabolism, Department of Internal Medicine, and Departments of bGeneral Surgery, cOtorhinolaryngology, dPathology and eRadiology, Karadeniz Technical University Faculty of Medicine, Trabzon, Turkey
email Corresponding Author

Dr. Cihangir Erem

Karadeniz Technical University Tıp Fakültesi

İç Hastalıkları Anabilim Dalı

TR–61080 Trabzon (Turkey)

Tel. +90 462 377 5449, Fax +90 462 325 2270, E-Mail cihangirerem@hotmail.com


  1. Astuti D, Latif F, Dallol A, Dahia PLM, Douglas F, George E, Sköldberg F, Husebye ES, Eng C, Maher ER: Gene mutations in the succinate dehydrogenase subunit SDHB, cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 2001;69:49–54.
  2. Pacak K, Linehan WM, Eisenhofer G, Walther MM, Goldstein DS: Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Intern Med 2001;134:315–329.
  3. Neumann HP, Bausch B, McWhinney SR, et al: Genetic germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 2002;346:1459–1466.
  4. Pritchett JW: Familial concurrence of carotid body tumor and pheochromocytoma. Cancer 1982;49:2578–2579.
  5. Doppman JL, Reinig JW, Dweyer AJ, et al: Differentiation of adrenal masses by magnetic resonance imaging. Surgery 1987;102:1018–1026.
  6. Sheps SG, Jiang NS, Klee GG, van Heerden JA: Recent developments in the diagnosis and treatment in pheochromocytoma. Mayo Clin Proc 1990;65:88–99.
  7. Walther MM, Keiser HR, Linehan WM: Pheochromocytoma: evaluation, diagnosis, and treatment. World J Urol 1999;17:35–39.
  8. Shapiro B, Fig LM: Management of pheochromocytoma. Endocrinol Metab Clin North Am 1989;18:443–481.
  9. Maher ER, Eng C: The pressure rises: update on the genetics of phaeochromocytoma. Hum Mol Genet 2002;11:2347–2354.
  10. Baysal BE, Ferrell RE, Willett-Brozick JE, et al: Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 2000;287:848–851.
  11. Astuti D, Hart-Holden N, Latif F, et al: Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility. Clin Endocrinol 2003;59:729–733.
    External Resources
  12. Neumann HP, Pawlu C, Peczkowska M, et al: Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 2004;292:943–951.